Skip to main content
OpenTrials

Clinical trial condition

Dermatitis

Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.

1,523 public trials 180 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis trial results

Completed

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

NCT05923099

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • LEO Investigational Site Fountain Valley, California, United States
  • LEO Investigational Site Los Angeles, California, United States
  • LEO Investigational Site San Francisco, California, United States
  • LEO Investigational Site Hialeah, Florida, United States
View all 73 locations
View Trial Details
Completed

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

NCT04541810

Conditions
Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +30 more
Locations
  • Inje University - Busan Paik Hospital /ID# 259143 Busan, Busan Gwang Yeogsi, South Korea
  • Haeundae Bumin Hospital /ID# 238959 Busan, Busan Gwang Yeogsi, South Korea
  • Inje University Haeundae Hospital /ID# 238949 Busan, Busan Gwang Yeogsi, South Korea
  • Dong-A University Medical Center /ID# 269937 Busan, Busan Gwang Yeogsi, South Korea
View all 116 locations
View Trial Details
Completed

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

NCT06283550

Conditions
Chronic Hand Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • INNO-6052 Site 12 Fredericton, New Brunswick, Canada
  • INNO-6052 Site 13 Cobourg, Ontario, Canada
  • INNO-6052 Site 11 Montreal, Quebec, Canada
  • INNO-6052 Site 19 Krakow, Poland
View Trial Details
Completed

Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)

NCT06945458

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Kymera Investigative Site Birmingham, Alabama, United States
  • Kymera Investigative Site Fountain Valley, California, United States
  • Kymera Investigative Site Santa Monica, California, United States
  • Kymera Investigative Site Boynton Beach, Florida, United States
View Trial Details
Completed

A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

NCT06438263

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Fortrea Clinical Research Unit - Daytona Beach Daytona Beach, Florida, United States
  • Fortrea Clinical Research Unit - Dallas Dallas, Texas, United States
  • Fortrea Clinical Research Unit Inc. - Madison Madison, Wisconsin, United States
View Trial Details
Completed

A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT05704738

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Cahaba Dermatology and Skin Health Center Birmingham, Alabama, United States
  • AllerVie Clinical Research- Cullman Cullman, Alabama, United States
  • Eclipse Clinical Research Tucson, Arizona, United States
  • Arkansas Research Trials, LLC North Little Rock, Arkansas, United States
View all 246 locations
View Trial Details

Related conditions